Once a new idea or novel drug is identified in the laboratory, the FDA requires three levels of clinical testing prior to the approval of that drug for widespread use. These studies are usually referred to as trials in Phase I, II, or III. The focus of a Phase I trial is to determine the appropriate dose and schedule of a given drug and its side effects. Patients enrolled usually have advanced cancers, which have progressed through standard therapy or for which standard therapy does not exist. Sometimes these patients have been through "everything" and still function extremely well.
With your support PHASE ONE hopes that its efforts to fund Phase I trials and research will help in the fight against cancer, by finding treatments that will transform what might be a terminal illness into one where patients can live a full and productive life.
Visit website: http://www.phaseonefoundation.org
